Conorfone

Conorfone is a synthetic opioid analgesic developed in the mid-1970s by the pharmaceutical company Conor Medsystems. It is a potent analgesic that has been used in the treatment of severe pain, often associated with terminal illnesses such as cancer.

Pharmacology

Conorfone is a mu-opioid receptor agonist. It works by binding to the mu-opioid receptors in the brain and spinal cord, blocking the transmission of pain signals. This results in a decrease in the perception of pain. Conorfone is also known to have a high affinity for the delta-opioid receptor, which may contribute to its analgesic effects.

Clinical Use

Conorfone is used in the management of moderate to severe pain, particularly in patients with terminal illnesses. It is often used when other, less potent analgesics are ineffective. Due to its potency and potential for addiction, it is typically reserved for use in patients with severe, chronic pain that is not responsive to other treatments.

Side Effects

Like other opioids, Conorfone can cause a number of side effects. These can include nausea, vomiting, constipation, and drowsiness. More serious side effects can include respiratory depression, dependence, and overdose.

Regulation

Due to its potential for abuse and addiction, Conorfone is classified as a Schedule II controlled substance in the United States. This means it is legal for medical use, but its distribution is tightly controlled and it is illegal to possess without a prescription.

See Also

• Opioid
• Analgesic
• Mu-opioid receptor
• Delta-opioid receptor
• Schedule II controlled substance

References

<references />

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

• 
•